Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|June 23, 2004
The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNKRenae K Barr, Ingrid Boehm, Paul V Attwood, et al.
Quantitative Imaging in Medicine and Surgery|May 9, 2024
Immediate hypersensitivity reactions to iodinated contrast media despite drug prophylaxis-a comparative retrospective cohort study of breakthrough reactions in Bern (Switzerland) and Seoul (South Korea)Lukas Beiner, Jiung Jeong, Dong Yoon Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2013
The anti-CD19 antibody-drug conjugate SAR3419 prevents hematolymphoid relapse postinduction therapy in preclinical models of pediatric acute lymphoblastic leukemiaHernan Carol, Barbara Szymanska, Kathryn Evans, et al.
Journal of Clinical Microbiology|June 7, 2003
Rapid detection of vanA and vanB genes directly from clinical specimens and enrichment broths by real-time multiplex PCR assaySilvano Palladino, Ian D Kay, James P Flexman, et al.
Pediatric Blood & Cancer|September 10, 2014
Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing ProgramHernan Carol, Mannie M Y Fan, Troy O Harasym, et al.
Journal of Molecular and Genetic Medicine : an International Journal of Biomedical Research|January 16, 2010
Heterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell cultureJohn S Sullivan, Paul W Selleck, Teena Downton, et al.
Plos One|April 6, 2012
Pharmacokinetic modeling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenograftsBarbara Szymanska, Urszula Wilczynska-Kalak, Min H Kang, et al.
Clinical and Vaccine Immunology : CVI|October 5, 2007
High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirusFang F Yuan, Ingrid Boehm, Paul K S Chan, et al.
Plos One|August 20, 2011
Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104Juliana Benito, Yuexi Shi, Barbara Szymanska, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2011
Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancerHernan Carol, Ingrid Boehm, C Patrick Reynolds, et al.
Pageof 3